Soleno not preannouncing Q3 sales ‘disappointing,’ says STAT’s Feuerstein

Adam Feuerstein, biotech reporter for STAT News, stated in a post to X: “$SLNO did not preannounce Q3 sales. That’s disappointing, as much as disclosure of preliminary Vykat XR sales for Q3 was a possibility to counter the bear thesis. Looks like we need to wait for the scheduled earnings report on Nov. 4.”